Upcoming Webinars
-
Ripped from the Headlines: Hot Topics in Life Sciences 2026
The life sciences industry is constantly changing, and equally dynamic are the challenges industry participants encounter. Join Medmarc's Risk Managers to discuss these changes from 2026.
Register for Ripped from the Headlines: Hot Topics in Life Sciences 2026 Read More about Ripped from the Headlines: Hot Topics in Life Sciences 2026 -
Claims 2026: Navigating an Increasingly Difficult World for Life Sciences
Join Andy Hall as he gives an update on the claims and legal environment for life science companies.
Register for Claims 2026: Navigating an Increasingly Difficult World for Life Sciences Read More about Claims 2026: Navigating an Increasingly Difficult World for Life Sciences
Past Webinars
-
FDA Outlook: What to Expect in 2021
With the ongoing COVID-19 pandemic, a transition to the new Biden administration (including a new FDA Commissioner), and shifting control of the Senate, uncertainty remains the one constant. In this...
Read More about FDA Outlook: What to Expect in 2021 -
Claims 2020: A Year Unlike Any Other
In this year’s annual year-end wrap-up, a panel that includes members of Medmarc’s Claims team along with David Waxman of Saul Ewing Arnstein & Lehr LLP will summarize the state of the medical...
Read More about Claims 2020: A Year Unlike Any Other -
Ripped From the Headlines: A(n Eventful) Year in Review
In this installment of Medmarc’s webinar series, Kate Klaus, an attorney and FDA specialist in our Risk Management department, will guide a discussion of the top life sciences news stories of the...
Read More about Ripped From the Headlines: A(n Eventful) Year in Review -
The Potential Life Sciences Implications of the Election
The medtech industry has significantly changed during the Trump administration’s last four years. FDA processes are streamlined, the medical device excise tax repealed, and the Senate is in the...
Read More about The Potential Life Sciences Implications of the Election